Lymphatic vessel invasion detected by the endothelial lymphatic marker D2-40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patients with resected esophageal cancer

Folia Histochemica et Cytobiologica

Volumn 49, Issue 1, 2011, Pages 90-97

  Kozłowski, Mirosław ^a   Naumnik, Wojciech ^a   Nikliński, Jacek ^a   Milewski, Robert ^a   Łapuć, Grzegorz ^a   Laudański, Jerzy ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

D2 40; Esophageal cancer; Lymph node metastasis; Lymphatic vessel invasion; Podoplanin; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; PODOPLANIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN DETERMINATION; SURVIVAL TIME;

EID: 79958178361     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0013     Document Type: Article

References (31)

1. Ielpo B, Pernaute AS, Elia S et al. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction. Interact Cardiovasc Thorac Surg. 2010;10:704-708.
2. Kranzfelder M, Büchler P, Friess H. Surgery within multimo-dal therapy concepts for esophageal squamous cell carcinoma (ESCC): the MRI approach and review of the literature. Adv Med Sci. 2009;54:158-169.
3. Wilson M, Rosato EL, Chojnacki KA et al. Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res. 2008;146:11-15.
4. Breiteneder-Geleff S, Soleiman A, Kowalski H et al. Angiosar-comas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154:385-394.
5. Banerji S, Ni J, Wang SX et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyalu-ronan. J Cell Biol. 1999;144:789-801.
6. Wigle J T, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;98:769-778.
7. Nathanson SD. Insights into the mechanisms of lymph node metastasis. Cancer. 2003;98:413-423.
8. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2:573-583.
9. Shayan R, Achen MG, Stacker SA. Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis. 2006;27: 1729-1738.
10. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775-784.
11. Ishii M, Ota M, Saito S, Kinugasa Y, Akamoto S, Ito I. Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer. Int J Colorectal Dis. 2009;24:1069-1074.
12. Birner P, Obermair A, Schindl M, Kowalski H, Breitenecker G, Oberhuber G. Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin Cancer Res. 2001;7:93-97.
13. Clemente CG, Boracchi P, Andreola S, Del Vecchio M, Vero-nesi P, Rilke FO. Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer. 1992;69:1396-1403.
14. von Rahden BH, Stein HJ, Feith M, Becker K, Siewert JR. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogas-tric junction. J Clin Oncol. 2005;23:874-879.
15. Brücher BL, Stein HJ, Werner M, Siewert JR. Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma. Cancer. 2001; 92: 2228-2233.
16. Alexander-Sefre F, Singh N, Ayhan A, Salveson HB, Wilbanks G, Jacobs IJ. Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemis-try. J Clin Pathol. 2003;56:786-788.
17. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol. 2002;15:434-440.
18. Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M. Up-regulation of the lymphatic marker podopla-nin, a mucin-type transmembrane glycoprotein, in human squa-mous cell carcinomas and germ cell tumors. Am J Pathol. 2005;166:913-921.
19. Yonemura Y, Endou Y, Tabachi K et al. Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol. 2006;37:1193-1199.
20. Matsumoto K, Nakayama Y, Inoue Y et al. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer. Dis Colon Rectum. 2007;50:308- 314.
21. Braun M, Wardelmann E, Debald M et al. Detection of lym-phovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases. Onkolo-gie. 2009;32:732-738.
22. Marinho VF, Metze K, Sanches FS, Rocha GF, Gobbi H. Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis. BMC Cancer. 2008;8:64-73.
23. Kawamura L, Carvalho FM, Alves BG et al. Association between intratumoral lymphatic microvessel density (LMVD) and clinicopathologic features in endometrial cancer: a retrospective cohort study. World J Surg Oncol. 2010;8:89-96.
24. Liersch R, Biermann C, Mesters RM, Berdel WE. Lymphan-giogenesis in cancer: current perspectives. Recent Results Cancer Res. 2010;180:115-135.
25. Inoue A, Moriya H, Katada N et al. Intratumoral lymphan-giogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. Pathol Int. 2008;58:611-619.
26. Tomita N, Matsumoto T, Hayashi T et al. Lymphatic invasion according to D2-40 immunostaining is a strong predictor of nodal metastasis in superficial squamous cell carcinoma of the esophagus: algorithm for risk of nodal metastasis based on lymphatic invasion. Pathol Int. 2008;58:282-287.
27. Rice T W, Zuccaro G Jr, Adelstein DJ, Rybicki LA, Black-stone EH, Goldblum JR. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65:787-792.
28. Gurleyik G, Gurleyik E, Aker F et al. Lymphovascular invasion, as a prognostic marker in patients with invasive breast cancer. Acta Chir Belg. 2007;107:284-287.
29. Liang P, Nakada I, Hong JW et al. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis. Ann Surg Oncol. 2007;14:470-477.
30. Ichikawa D, Kubota T, Kikuchi S et al. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. J Surg Oncol. 2009;100:111-114.
31. Hyung WJ, Lee JH, Choi SH, Min JS, Noh SH. Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol. 2002;9:562-567.